Welcome to LookChem.com Sign In|Join Free
  • or
2-amino-quinoline-6-carboxylic acid tert-butyl ester is a substituted quinoline compound characterized by the presence of an amino group at the 2nd position and a tert-butyl ester group at the 6th position of the quinoline ring. This organic molecule is known for its potential applications in the pharmaceutical industry.

863492-32-4

Post Buying Request

863492-32-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

863492-32-4 Usage

Uses

Used in Pharmaceutical Industry:
2-amino-quinoline-6-carboxylic acid tert-butyl ester is used as a therapeutic agent for the treatment of obesity and related conditions. Its unique structure allows it to target specific biological pathways involved in weight regulation and metabolic processes, offering a promising approach to managing obesity and associated health issues.

Check Digit Verification of cas no

The CAS Registry Mumber 863492-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,3,4,9 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 863492-32:
(8*8)+(7*6)+(6*3)+(5*4)+(4*9)+(3*2)+(2*3)+(1*2)=194
194 % 10 = 4
So 863492-32-4 is a valid CAS Registry Number.

863492-32-4Relevant academic research and scientific papers

Safe and practical large-scale synthesis of 2-aminoquinoline-6-carboxylic acid benzyl ester

Couturier, Michel,Le, Tung

, p. 534 - 538 (2012/12/22)

An efficient three-step sequence has been developed for the synthesis of 2-aminoquinoline-6-carboxylic acid benzyl ester starting from commercially available 6-quinolinecarboxylic acid. The process features a novel and exceptionally mild conversion of a q

SUBSTITUTED QUINOLINE COMPOUNDS

-

Page/Page column 69-70, (2008/06/13)

This invention relates to MTP/Apo-B secretion inhibitors of Formula (I) wherein R1-R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 863492-32-4